Lysates from eight EGFR-mutant, four KRAS-mutant, and two EGFR/KRAS wild-type LUAD, as well as two large cell carcinoma and four SCLC cell lines were assessed (Figure 1—figure supplement 1a). This evidence concerns the gene EGFR and small cell lung carcinoma.